PT Bumi Resources Tbk (IDX:BUMI)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions IDR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 5, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	41,589,564	43,817,576	31,562,260	23,158,440	4,976,408	4,912,467
Market Cap Growth	52.57%	38.83%	36.29%	365.37%	1.30%	13.68%
Enterprise Value	64,922,066	66,025,276	52,962,133	55,969,036	37,885,197	36,725,487
Last Close Price	112.00	118.00	85.00	161.00	67.00	72.00
PE Ratio	862.38	40.34	187.45	2.84	2.08	-
Forward PE	-	1.76	1.76	1.76	1.76	1.76
PS Ratio	1.78	2.00	1.22	0.82	0.35	0.45
PB Ratio	0.91	0.95	0.74	0.53	0.54	2.66
P/TBV Ratio	1.69	1.74	1.37	0.98	-	-
EV/Sales Ratio	2.77	3.02	2.05	1.97	2.64	3.34
EV/EBITDA Ratio	20.02	52.94	51.64	16.72	18.80	-
EV/EBIT Ratio	25.32	70.58	66.94	17.62	20.88	-
Debt / Equity Ratio	0.10	0.11	0.11	0.09	2.43	12.34
Debt / EBITDA Ratio	1.87	3.17	3.22	1.01	9.41	-
Asset Turnover	0.36	0.33	0.39	0.42	0.26	0.23
Inventory Turnover	27.42	38.23	50.86	41.96	27.92	25.09
Quick Ratio	0.40	0.42	0.33	0.47	0.18	0.23
Current Ratio	1.01	1.00	0.90	0.84	0.27	0.31
Return on Equity (ROE)	1.26%	3.20%	0.96%	32.13%	57.34%	-122.29%
Return on Assets (ROA)	1.55%	0.87%	0.74%	2.94%	2.08%	-1.36%
Return on Capital (ROIC)	2.02%	1.16%	1.04%	4.84%	3.99%	-2.63%
Return on Capital Employed (ROCE)	3.10%	1.70%	1.50%	5.70%	9.50%	-
Earnings Yield	0.12%	2.48%	0.53%	35.22%	48.10%	-95.84%
FCF Yield	-1.09%	-1.11%	-8.20%	-48.51%	-89.72%	-5.74%
Buyback Yield / Dilution	-6.47%	0.00%	-121.72%	-126.39%	-8.42%	-4.20%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.